medigraphic.com
ISSN 1995-9427 (Print)

2019, Number 2

<< Back Next >>

Invest Medicoquir 2019; 11 (2)

Current status of interventional procedures in the breast

Ugarte MD, Miñoso AY, García MN, Martínez QJA, Rosales VT, Ugarte SJC

Language: Spanish
References: 26
Page: 1-15
PDF size: 209.53 Kb.


ABSTRACT

The radiologist in the field of the breast has been acquiring new responsibilities, which include the early detection of breast cancer, the accurate diagnosis using imaging modalities such as mammography, ultrasound and magnetic resonance imaging.
To this is added: percutaneous biopsy, assessment of local extension and response to neoadjuvant chemotherapy, by magnetic resonance, and in the evolution of the patients treated. The interventionism has completed its participation in this field. With the diagnostic interventionism techniques such as: fine needle cytology, thick needle biopsy, vacuum assisted biopsy, percutaneous excisional biopsy and galactography. In addition to therapeutic intervention, which includes: removal with percutaneous biopsy devices, removal by thermal ablation techniques, radiotracer injection for sentinel lymph node localization and tumor labeling for primary chemotherapy. Its contribution to early and accurate diagnosis, to the performance of more appropriate surgical interventions and the evolutionary follow-up of patients treated by different modalities; they make their participation almost essential in the general management of this disease.


REFERENCES

  1. Lee CH. Screening mammography: proven benefit, continued controversy. Radiol.Clin N Am. 2002;40:395-407.

  2. Liberman L. Percutaneous image-guided core breast biopsy.RadiolClin N Am. 2002;40:483-500.

  3. Ministerio de Salud Pública. Dirección Nacional de Registros Médicos y Estadísticas de salud. Anuario Estadístico de Salud, 2016. La Habana. Disponible en: http://files.sld.cu/dne/files/2010/04/anuario-2016e3.pdf

  4. Apesteguía L. Manejo de pacientes de alto riesgo de cáncer de mama. Radiol. 2010;52(S1):18-21.

  5. Mellado M, Osa AM. Cribado de cáncer de mama. Estado actual.Radiol. 2013;55(4):305-14.

  6. Meyer JE, Smith DN, Lester SC, Kaelin C, DiPiro PJ, Denison CM, et al. Large-core needle biopsy of nonpalpable breast lesions. JAMA. 1999;281:1638-41.

  7. Norton LW, Zeligman BE, Pearlman NW. Accuracy and cost of needle localization breast biopsy. Arch.Surg 1988; 123: 947-950.

  8. Canavese G, Catturich A, Vecchio C, Tomei D, Estieme M, Moresco L et al. Preoperative localization of nonpalpable lesions in breast cancer by charcoal suspension.Eur J Surg.Oncol 1995; 21: 47-49.

  9. Langlois S, Carter ML. Carbon localisation of impalpable mammographic abnormalities. Australas Radiol 1991; 35: 237-241.

  10. Ruiz-Delgado MA, López-Ruiz JA, Sáiz-López A. Abnormal mammography and sonography associated with foreign-body giant-cell reaction after stereotactic vacuum-assisted breast biopsy with carbon marking. Acta Radiol. 2008;49:1112-8.

  11. Mariscal A, Balliu E, Solà M, Pérez de Tudela A, Fraile M, Julián JF. Comparación entre la inyección intra-tumoral y peri-tumoral del radiotrazador para la localización y biopsia del ganglio centinela, en cáncer de mama no palpable. Radiologia.2008;50:309-16.

  12. Iciar Pascual M. Valoración de la técnica de SNOLL en la exéresis de microcalcificaciones mamarias malignas (tesis doctoral). Hospital UniversitariGermans Tries I Pujol. Universidad Autónoma de Barcelona; 2012.

  13. Mendoza I, R. Sánchez R, Culiañez M, Moyano A, Muñoz T, Martínez S. Arpón quirúrgico vs semilla de iodo (125i) en la localización de lesiones no palpables de mama. Resultados preliminares. SERAM. Elsevier España, 2018.

  14. Vega A, Alonso P, Ortega E, Garijo F. Ultrasound-guidedcoreneedlebiopsy of non-palpable breastlesions: a prospectiveanalysis in 204 cases. Acta Radiol. 2005; 46:690-695.

  15. López JA, Saralegui I, Iturraspe CG, Echevarría JJ, Zabalza I, Álvarez J. Punción Aspirativa con Aguja Fina (PAAF) de lesiones no palpables: aspectos técnicos, indicaciones y valor diagnóstico (revisión de 1.000 casos). Rev SenologiaPatol Mam. 1997;10:161-73.

  16. Fitzal F, Sporn EP, Draxler W, Mittlböck M, Taucher S, Rudas M, et al. Preoperative core needle biopsy does not increase local recurrence rate in breast cancer patients. Breast Cancer Res Treat. 2006 May;97(1)::9-

  17. Vega A, Alonso P, Ortega E, Garijo F. Ultrasound-guided core needle biopsy of non-palpable breast lesions: a prospective analysis in 204 cases. Acta Radiol.2005 Nov;46(7):690-5.

  18. Youk JH, Kim EK, Kim MJ, Oh KK.Sonographically guided14-gauge core needle biopsy of breast masses: a review of 2,420 cases with long-term follow-up. AJR Am J Roentgenol.2008 Jan;190(1):202-7.

  19. Alonso P, Vega A, Torres M, Ortega E, Acebal M, Garijo F, et al. Sonographically guided 11G directional vacuum-assisted breast biopsy as an alternative to surgical excision: utility and cost study in probably benign lesions. Acta. Radiol.. 2004 Jul;45(4):390-6.

  20. Esen G, Tutar B, Uras C, Calay Z, İnce Ü, Tutar O. Vacuum-assisted stereotactic breast biopsy in the diagnosis and management of suspicious microcalcifications. DiagnIntervRadiol. 2016;22(4):326-33.

  21. Slawson SH, Johnson BA. Ductography: how to and what If? Radiographics. 2001 Jan-Feb;21(1):133-50.

  22. Peek MC, Ahmed M, Napoli A, Haken B, McWilliams S, Usiskin S, Pinder S, et al. Systematic review of high-intensity focused ultrasound ablation in the treatment of breast cancer. Br J Surg. 2015 Jul;102(8):873-82.

  23. Kinoshita T. RFA experiences, indications and clinical outcomes. Int J ClinOncol. 2019 Jun;24(6):603-607.

  24. Takada M, Toi M. Cryosurgery for primary breast cancers, its biological impact, and clinical outcomes. Int J ClinOncol. 2019;24(6):608-613.

  25. Zeitoun J, Babin G, Lebrun JF. Sentinel node and breast cancer: A state-of-the-art in 2019. GynecolObstetFertilSenol. 2019;5(19):121-7.

  26. Goto L, Yamamoto M, Yamamoto Y, Fujiki Y, Tomiguchi M, Sueta A, Takeshita T, et al. Therapeutic predictors of neoadjuvant endocrine therapy response in estrogen receptor-positive breast cancer with reference to optimal gene expression profiling. Breast Cancer Res Treat. 2018 Nov;172(2):353-362.




2020     |     www.medigraphic.com